Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value: $185M (100.0% shares, 0.0% debt)

Holdings (27)

— Viveve Medical, Inc 14.9%

Value $27.51M Shares 3,849,711 Share Price $7.15 Est. Cost/Share $6.92 Unrealized @ Report Date —

ENTA Enanta Pharmaceuticals 9.6%

Value $17.71M Shares 492,265 Share Price $35.98 * Est. Cost/Share $30.74 Unrealized @ Report Date +4.1%

— Novelion Therapeutics, Inc. 9.2%

Value $17.1M Shares 1,852,395 Share Price $9.23 Est. Cost/Share $8.59 Unrealized @ Report Date —

— Recro Pharma, Inc. 6.9%

Value $12.86M Shares 1,829,669 Share Price $7.03 Est. Cost/Share $8.20 Unrealized @ Report Date —

VNDA VANDA PHARMACEUTICALS INC 6.0%

Value $11.17M Shares 685,086 Share Price $16.30 * Est. Cost/Share $14.40 Unrealized @ Report Date +0.1%

VCEL Vericel Corp 5.3%

Value $9.836M Shares 2,980,570 Share Price $3.30 * Est. Cost/Share $2.65 Unrealized @ Report Date +3.4%

— Biodelivery Sciences INTL 5.3%

Value $9.737M Shares 3,477,673 Share Price $2.80 Est. Cost/Share $1.95 Unrealized @ Report Date —

— Ophthotech Corp 4.9%

Value $9.155M Shares 3,576,189 Share Price $2.56 Est. Cost/Share $4.39 Unrealized @ Report Date —

— Avadel Pharmaceuticals PLC 4.5%

Value $8.249M Shares 747,863 Share Price $11.03 Est. Cost/Share $9.68 Unrealized @ Report Date —

CPIX Cumberland Pharmaceuticals, Inc. 4.2%

Value $7.764M Shares 1,109,167 Share Price $7.00 * Est. Cost/Share $5.60 Unrealized @ Report Date +17.7%

— CTI Biopharmap Corp. 4.1%

Value $7.561M Shares 2,284,381 Share Price $3.31 Est. Cost/Share $3.31 Unrealized @ Report Date —

— Cardiome Pharma Corp 3.9%

Value $7.212M Shares 1,595,549 Share Price $4.52 Est. Cost/Share $2.98 Unrealized @ Report Date —

VCYT Veracyte, Inc. 3.9%

Value $7.203M Shares 864,695 Share Price $8.33 * Est. Cost/Share $7.70 Unrealized @ Report Date +5.9%

— Alere Inc. 2.7%

Value $5.019M Shares 100,000 Share Price $50.19 Est. Cost/Share $42.05 Unrealized @ Report Date —

— Durect Corporation 2.7%

Value $4.955M Shares 3,175,994 Share Price $1.56 Est. Cost/Share $1.33 Unrealized @ Report Date —

— Cutera Inc. 2.4%

Value $4.533M Shares 175,000 Share Price $25.90 Est. Cost/Share $25.90 Unrealized @ Report Date —

— Neos Therapeutics, Inc. 2.2%

Value $4.125M Shares 565,100 Share Price $7.30 Est. Cost/Share $7.30 Unrealized @ Report Date —

— Corium International, Inc. 1.7%

Value $3.085M Shares 413,568 Share Price $7.46 Est. Cost/Share $7.46 Unrealized @ Report Date —

— Biospecifics Technologies Co. 1.6%

Value $2.965M Shares 59,878 Share Price $49.52 Est. Cost/Share $49.52 Unrealized @ Report Date —

— Sciclone Pharmaceuticals, Inc. 1.3%

Value $2.379M Shares 216,307 Share Price $11.00 Est. Cost/Share $10.55 Unrealized @ Report Date —

— Trinity Biotech PLC - SPON ADR 1.0%

Value $1.872M Shares 311,994 Share Price $6.00 Est. Cost/Share $6.92 Unrealized @ Report Date —

— Depomed Inc. 0.7%

Value $1.36M Shares 126,600 Share Price $10.74 Est. Cost/Share $10.74 Unrealized @ Report Date —

— CAS Medical Systems Inc 0.6%

Value $1.044M Shares 900,366 Share Price $1.16 Est. Cost/Share $1.16 Unrealized @ Report Date —

— Amarin Corp PLC - SPONS ADR 0.2%

Value $302K Shares 75,000 Share Price $4.03 Est. Cost/Share $4.03 Unrealized @ Report Date —

— Alimera Sciences, Inc 0.1%

Value $257K Shares 184,827 Share Price $1.39 Est. Cost/Share $1.25 Unrealized @ Report Date —

CDNA CAREDX, Inc. 0.1%

Value $212K Shares 190,909 Share Price $1.11 Est. Cost/Share $1.06 Unrealized @ Report Date 0.0%

— Foamix Pharmaceuticals Ltd. 0.0%

Value $13,000 Shares 2,878 Share Price $4.52 Est. Cost/Share $4.52 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	Viveve Medical, Inc	3,849,711	$27.51M	14.9%	$7.15	$6.92	—	COM	92852W204
ENTA	Enanta Pharmaceuticals	492,265	$17.71M	9.6%	$35.98 *	$30.74	+4.1%	COM	29251M106
—	Novelion Therapeutics, Inc.	1,852,395	$17.1M	9.2%	$9.23	$8.59	—	COM	67001K202
—	Recro Pharma, Inc.	1,829,669	$12.86M	6.9%	$7.03	$8.20	—	COM	75629F109
VNDA	VANDA PHARMACEUTICALS INC	685,086	$11.17M	6.0%	$16.30 *	$14.40	+0.1%	COM	921659108
VCEL	Vericel Corp	2,980,570	$9.836M	5.3%	$3.30 *	$2.65	+3.4%	COM	92346J108
—	Biodelivery Sciences INTL	3,477,673	$9.737M	5.3%	$2.80	$1.95	—	COM	09060J106
—	Ophthotech Corp	3,576,189	$9.155M	4.9%	$2.56	$4.39	—	COM	683745103
—	Avadel Pharmaceuticals PLC	747,863	$8.249M	4.5%	$11.03	$9.68	—	SPONS ADR	05337M104
CPIX	Cumberland Pharmaceuticals, Inc.	1,109,167	$7.764M	4.2%	$7.00 *	$5.60	+17.7%	COM	230770109
—	CTI Biopharmap Corp.	2,284,381	$7.561M	4.1%	$3.31	$3.31	—	COM	12648L601
—	Cardiome Pharma Corp	1,595,549	$7.212M	3.9%	$4.52	$2.98	—	COM	14159U301
VCYT	Veracyte, Inc.	864,695	$7.203M	3.9%	$8.33 *	$7.70	+5.9%	COM	92337F107
—	Alere Inc.	100,000	$5.019M	2.7%	$50.19	$42.05	—	COM	01449J105
—	Durect Corporation	3,175,994	$4.955M	2.7%	$1.56	$1.33	—	COM	266605104
—	Cutera Inc.	175,000	$4.533M	2.4%	$25.90	$25.90	—	COM	232109108
—	Neos Therapeutics, Inc.	565,100	$4.125M	2.2%	$7.30	$7.30	—	COM	64052L106
—	Corium International, Inc.	413,568	$3.085M	1.7%	$7.46	$7.46	—	COM	21887L107
—	Biospecifics Technologies Co.	59,878	$2.965M	1.6%	$49.52	$49.52	—	COM	090931106
—	Sciclone Pharmaceuticals, Inc.	216,307	$2.379M	1.3%	$11.00	$10.55	—	COM	80862K104
—	Trinity Biotech PLC - SPON ADR	311,994	$1.872M	1.0%	$6.00	$6.92	—	SPONS ADR	896438306
—	Depomed Inc.	126,600	$1.36M	0.7%	$10.74	$10.74	—	COM	249908104
—	CAS Medical Systems Inc	900,366	$1.044M	0.6%	$1.16	$1.16	—	COM PAR	124769209
—	Amarin Corp PLC - SPONS ADR	75,000	$302K	0.2%	$4.03	$4.03	—	SPONS ADR	023111206
—	Alimera Sciences, Inc	184,827	$257K	0.1%	$1.39	$1.25	—	COM	016259103
CDNA	CAREDX, Inc.	190,909	$212K	0.1%	$1.11	$1.06	0.0%	COM	14167L103
—	Foamix Pharmaceuticals Ltd.	2,878	$13,000	0.0%	$4.52	$4.52	—	SHS	M46135105